Cargando…

Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection

Hand, foot, and mouth disease (HFMD) is a common childhood infectious disease caused by enterovirus (EV) infection. EV71 is one of the major pathogens causing hand, foot, and mouth disease and is more likely to cause exacerbation and death than other enteroviruses. Although a monovalent vaccine for...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Sai, Xie, Lei, Ma, Sen, Xu, Binghong, An, Hailong, Ye, Sheng, Wang, Yaxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017496/
https://www.ncbi.nlm.nih.gov/pubmed/36937869
http://dx.doi.org/10.3389/fphar.2023.1118584
_version_ 1784907599236300800
author Shi, Sai
Xie, Lei
Ma, Sen
Xu, Binghong
An, Hailong
Ye, Sheng
Wang, Yaxin
author_facet Shi, Sai
Xie, Lei
Ma, Sen
Xu, Binghong
An, Hailong
Ye, Sheng
Wang, Yaxin
author_sort Shi, Sai
collection PubMed
description Hand, foot, and mouth disease (HFMD) is a common childhood infectious disease caused by enterovirus (EV) infection. EV71 is one of the major pathogens causing hand, foot, and mouth disease and is more likely to cause exacerbation and death than other enteroviruses. Although a monovalent vaccine for EV71 has been developed, there are no clinically available anti-EV71 specific drugs. Here, we performed virtual screening and biological experiments based on the traditional Chinese medicine monomer library. We identified a traditional Chinese medicine monomer, Salvianolic acid A (SA), a polyphenolic compound isolated from Salvia miltiorrhiza. Salvianolic acid A inhibits EV71 virus infection in a concentration-dependent manner, and its antiviral activity is higher than that of other reported natural polyphenols and has a high biosafety. Furthermore, molecular dynamics simulations showed that salvianolic acid A can anchor to E71, a member of the enzyme catalytic triad, and cause H40 to move away from the catalytic center. Meanwhile, molecular mechanics generalized born surface area (MMGBSA) and steered molecular dynamics (SMD) results showed that the P1 group of SA was most easily unbound to the S1 pocket of 3C(pro), which provided theoretical support to further improve the affinity of salvianolic acid A with 3C(pro). These findings suggest that salvianolic acid A is a novel EV71 3C(pro) inhibitor with excellent antiviral activity and is a promising candidate for clinical studies.
format Online
Article
Text
id pubmed-10017496
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100174962023-03-17 Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection Shi, Sai Xie, Lei Ma, Sen Xu, Binghong An, Hailong Ye, Sheng Wang, Yaxin Front Pharmacol Pharmacology Hand, foot, and mouth disease (HFMD) is a common childhood infectious disease caused by enterovirus (EV) infection. EV71 is one of the major pathogens causing hand, foot, and mouth disease and is more likely to cause exacerbation and death than other enteroviruses. Although a monovalent vaccine for EV71 has been developed, there are no clinically available anti-EV71 specific drugs. Here, we performed virtual screening and biological experiments based on the traditional Chinese medicine monomer library. We identified a traditional Chinese medicine monomer, Salvianolic acid A (SA), a polyphenolic compound isolated from Salvia miltiorrhiza. Salvianolic acid A inhibits EV71 virus infection in a concentration-dependent manner, and its antiviral activity is higher than that of other reported natural polyphenols and has a high biosafety. Furthermore, molecular dynamics simulations showed that salvianolic acid A can anchor to E71, a member of the enzyme catalytic triad, and cause H40 to move away from the catalytic center. Meanwhile, molecular mechanics generalized born surface area (MMGBSA) and steered molecular dynamics (SMD) results showed that the P1 group of SA was most easily unbound to the S1 pocket of 3C(pro), which provided theoretical support to further improve the affinity of salvianolic acid A with 3C(pro). These findings suggest that salvianolic acid A is a novel EV71 3C(pro) inhibitor with excellent antiviral activity and is a promising candidate for clinical studies. Frontiers Media S.A. 2023-03-02 /pmc/articles/PMC10017496/ /pubmed/36937869 http://dx.doi.org/10.3389/fphar.2023.1118584 Text en Copyright © 2023 Shi, Xie, Ma, Xu, An, Ye and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Shi, Sai
Xie, Lei
Ma, Sen
Xu, Binghong
An, Hailong
Ye, Sheng
Wang, Yaxin
Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection
title Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection
title_full Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection
title_fullStr Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection
title_full_unstemmed Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection
title_short Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection
title_sort computational and experimental studies of salvianolic acid a targets 3c protease to inhibit enterovirus 71 infection
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017496/
https://www.ncbi.nlm.nih.gov/pubmed/36937869
http://dx.doi.org/10.3389/fphar.2023.1118584
work_keys_str_mv AT shisai computationalandexperimentalstudiesofsalvianolicacidatargets3cproteasetoinhibitenterovirus71infection
AT xielei computationalandexperimentalstudiesofsalvianolicacidatargets3cproteasetoinhibitenterovirus71infection
AT masen computationalandexperimentalstudiesofsalvianolicacidatargets3cproteasetoinhibitenterovirus71infection
AT xubinghong computationalandexperimentalstudiesofsalvianolicacidatargets3cproteasetoinhibitenterovirus71infection
AT anhailong computationalandexperimentalstudiesofsalvianolicacidatargets3cproteasetoinhibitenterovirus71infection
AT yesheng computationalandexperimentalstudiesofsalvianolicacidatargets3cproteasetoinhibitenterovirus71infection
AT wangyaxin computationalandexperimentalstudiesofsalvianolicacidatargets3cproteasetoinhibitenterovirus71infection